U.S. Cardiac Biomarkers Market Size & Outlook, 2026-2033

Name: U.S. Cardiac Biomarkers Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The cardiac biomarkers market in the United States is expected to reach a projected revenue of US$ 19,052.1 million by 2033. A compound annual growth rate of 12% is expected of the United States cardiac biomarkers market from 2026 to 2033.

Clinical Diagnostics
- Biomarkers
  - cardiac biomarker market

U.S. cardiac biomarker type outlook (Revenue, USD million, 2021-2033)
- Troponin
- CK-MB
- Myoglobin
- BNP and NT-proBNP
- Others
U.S. cardiac biomarker application outlook (Revenue, USD million, 2021-2033)
- Acute Coronary Syndrome
- Myocardial Infarction
- Congestive Heart Failure
- Others
U.S. cardiac biomarker end use outlook (Revenue, USD million, 2021-2033)
- Laboratory Testing
- Point of Care Testing

U.S. Cardiac Biomarkers Market Size & Outlook, 2026-2033

Data Tree

Sign up - it's easy, and free!